About
Lyterian Therapeutics develops medicines that leverage protein homeostasis mechanisms to regulate genetically validated targets for treating diseases.
Explore Lyterian Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.